PAGE 1
HOUSE BILL 1502

J1 5lr3585
CF 5lr3586

By: Delegate Wells (By Request – Baltimore City Administration)
Introduced and read first time: February 14, 2025
Assigned to: Rules and Executive Nominations
Re–referred to: Health and Government Operations, February 25, 2025

Committee Report: Favorable
House action: Adopted
Read second time: March 6, 2025

CHAPTER ______

1 AN ACT concerning

2 Baltimore City – AIDS Prevention Sterile Needle and Syringe Exchange Pilot
3 Program – Revisions

4 FOR the purpose of renaming the AIDS Prevention Sterile Needle and Syringe Exchange
5 Pilot Program to be the HIV Prevention Syringe Services Program; altering the
6 duties of the Program, the Director of the Program, and the Baltimore City Health
7 Department regarding the Program; altering the membership and duties of the
8 Program’s oversight committee; altering the immunity provided to Program staff and
9 participants; and generally relating to the AIDS Prevention Sterile Needle and
10 Syringe Exchange Pilot Program.

11 BY repealing and reenacting, without amendments,
12 Article – Health – General
13 Section 24–801(a)
14 Annotated Code of Maryland
15 (2023 Replacement Volume and 2024 Supplement)

16 BY repealing and reenacting, with amendments,
17 Article – Health – General
18 Section 24–801(e), 24–802 through 24–806, 24–808, and 24–809
19 Annotated Code of Maryland
20 (2023 Replacement Volume and 2024 Supplement)

EXPLANATION: CAPITALS LAW.INDICATE MATTER ADDED TO EXISTING
[Brackets] indicate matter deleted from existing law.
Underlining indicates amendments to bill.
~~Strike~~ ~~out~~ indicates matter stricken from the bill by amendment or deleted from the law by
amendment. *hb1502*

PAGE 2
2 HOUSE BILL 1502

1 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
2 That the Laws of Maryland read as follows:

3 Article – Health – General

4 24–801.

5 (a) In this subtitle the following words have the meanings indicated.

[AIDS] HIV [Sterile and]6 (e) “Program” means the Prevention Needle Syringe
[Exchange Pilot] SERVICES7 Program.

8 24–802.

[AIDS] HIV [Sterile and] [Exchange9 (a) There is an Prevention Needle Syringe
Pilot] SERVICES10 Program in the Baltimore City Health Department.

11 (b) The Program shall:

[Provide] DISTRIBUTE12 (1) for the exchange bySYRINGES AND PROVIDE
13 participants of used hypodermic needles and syringes for sterile hypodermic needles and
14 syringes NEEDED; andAS

15 (2) Operate in accordance with the procedures approved, with the advice
16 and approval of the oversight committee, by the Commissioner of Health.

17 24–803.

18 The Program shall:

[maximum19 (1) Be designed and maintained to provide security of exchange
including] [that be]20 locations and equipment, security measures may AND PROCESSES
[control of]21 required to the use and dispersal hypodermic needlesSAFELY DISTRIBUTE
[security of]22 and syringes and measures that allow for a full accounting theACCOUNT FOR
[in circulation]23 number of hypodermic needles and syringes EXCHANGED AND
BALTIMORE CITY HEALTH DEPARTMENT24 and the number ofDISTRIBUTED BY THE
25 hypodermic needles and syringes in storage;

26 (2) Be operated to allow participants to exchange used hypodermic needles
[any is]27 and syringes at exchange location, if more than one location available MOBILE
28 SITES;SYRINGE SERVICES

29 (3) Include appropriate levels of staff expertise in working with injecting
30 drug users and adequate staff training in providing community SERVICE PROVIDER
31 referrals, counseling, and preventive education;

PAGE 3
HOUSE BILL 1502 3

[curtailing1 (4) Provide for the dissemination of other preventive means for
infection] HIV2 the spread of the HIV TRANSMISSION;DECREASING THE RISK OF

[a for]3 (5) Provide linkage referrals to drug counseling and treatment
4 services, and follow–up to those referrals to assure that participants receive the treatment
5 they desire;

[dangers6 (6) Educate injecting drug users on the of contracting the HIV
infection] HIV HIGH–RISK7 or the hepatitis B virus throughRISK OF TRANSMITTING
[unsafe]8 needle–sharing practices and sexual behaviors;

9 (7) Include policies and procedures for the screening of applicants to the
10 Program in order to preclude noninjecting drug users from participating in the Program;
11 AND

[Establish] IMPLEMENT12 (8) procedures for identifying Program
subtitle[;13 participants that are consistent with the confidentiality provisions of this and

14 (9) Establish a method of identification and authorization for Program staff
records].15 members who have access to hypodermic needles, syringes, or Program

16 24–804.

17 (a) The Mayor of Baltimore City shall appoint an oversight committee for the
18 Program.

19 (b) The oversight committee shall consist of:

[Two representatives] ONE20 (1) from academia whoREPRESENTATIVE
[specialize]21 in public health issues;SPECIALIZES

enforcement[,22 (2) One representative from law nominated by the Secretary
Services];23 of Public Safety and Correctional

[(3) Department;]24 One representative of the Baltimore City Police

[(4)] (3) [Two representatives] ONE25 from theREPRESENTATIVE
Health[,26 Maryland Department of the Department of Juvenile Services, or the Department
Health];27 of Education, nominated by the Secretary of

[(5)] (4)28 One representative of a Baltimore City community group;

[(6)] (5) [AIDS] HIV29 One representative of an advocacy group;

[(7)] (6) [drug abuse]30 One treatment counselor;ADDICTION

PAGE 4
4 HOUSE BILL 1502

[(8)] (7)1 One recovering injecting drug user; and

[(9)] (8) [Mayor2 Up to three other individuals whom the of Baltimore
City] BALTIMORE CITY HEALTH DEPARTMENT3 determines to be appropriate for
4 appointment to the oversight committee.

5 (c) The oversight committee shall:

6 (1) Provide advice to the Commissioner of Health and the Program Director
7 on developing NECESSARY:AND REVISING AS

[furnishing]8 (i) Program operating procedures for the
9 and exchange of hypodermic needles and syringes to injecting drug users;DISTRIBUTION

10 (ii) A plan for community outreach and education;

[a linkage]11 (iii) A protocol for providing for ProgramREFERRALS
[substance abuse]12 participants to treatment and rehabilitation; andADDICTION

13 (iv) A plan for evaluating the Program; and

14 (2) Provide ongoing oversight of the Program and make recommendations
15 to the Program Director or the Commissioner of Health regarding any aspect of Program
16 procedures, operation, or evaluation.

17 24–805.

18 (a) The Commissioner of Health shall appoint a Director for the Program.

[and approval]19 (b) With the advice of the oversight committee, the Director shall
20 develop NECESSARY:AND REVISE AS

[furnishing]21 (1) Program operating procedures for the andDISTRIBUTION
22 exchange of hypodermic needles and syringes to injecting drug users;

23 (2) A community outreach and education program; and

[a linkage]24 (3) A protocol for providing for ProgramREFERRALS
25 participants to substance abuse treatment and rehabilitation.

26 (c) The Director shall submit the operating procedures, the plan for a community
[substance abuse]27 outreach and education program, and the treatmentADDICTION
[linkage] COMMISSIONER’S28 protocol to the Commissioner of HealthREFERRAL OR THE
29 for approval prior to implementation PROCEDURES.DESIGNEE THE OF REVISED

PAGE 5
HOUSE BILL 1502 5

1 24–806.

2 (a) The Baltimore City Health Department shall include in its Program operating
3 procedures measures to collect the following data:

4 (1) The number of participants served by the Program;

5 (2) The length of time a participant is served by the Program;

6 (3) Demographic profiles of participants served by the Program that
7 include:

8 (i) Age;

9 (ii) Sex;

10 (iii) Race; AND

[(iv) Occupation;]11

[(v)] (IV)12 Zip code of residence;

[(vi)13 Types of drugs used;

14 (vii) Length of drug use; and

injection;]15 (viii) Frequency of

16 (4) The number of hypodermic needles and syringes exchanged;

[entering and]17 (5) The number of participants drug counseling REFERRED
18 treatment; andTO ADDICTION

[drug and]19 (6) The number of referrals made by the Program for counseling
20 treatment DRUGS.ADDICTION FOR PEOPLE WHO INJECT

[and approval]21 (b) With the advice of the oversight committee, the Baltimore City
22 Health Department shall develop and implement a plan for Program evaluation that shall
23 include the following issues:

24 (1) The prevalence of HIV among ProgramESTIMATED AND INCIDENCE
25 participants;

[(2)26 Changes in the level of drug use among Program participants;

27 (3) Changes in the level of needle–sharing among Program participants;

PAGE 6
6 HOUSE BILL 1502

1 (4) Changes in the use of condoms among Program participants;

2 (5) The status of treatment and recovery for Program participants who
3 entered drug treatment programs;

4 (6) The impact of the Program on risk behaviors for the transmission of the
5 HIV infection, the hepatitis B virus, and other life–threatening blood–borne diseases
6 among injecting drug users;

7 (7) The cost–effectiveness of the Program versus the direct and indirect
8 costs of the HIV infection in terms of medical treatment and other services normally
individuals;]9 required by HIV–infected

[(8)] (2)10 The strengths and weaknesses of the Program; and

[(9)] (3)11 The advisability of continuing the Program.

12 (c) As part of its plans for data collection and Program evaluation described under
13 subsections (a) and (b) of this section, the Baltimore City Health Department shall develop
methodology[:14 and implement a

15 (1) For identifying Program hypodermic needles and syringes, such as
16 through the use of bar coding or any other method approved by the oversight committee;
17 and

18 (2) To perform HIV antibody testing on the residue left in a sample of
Program]19 hypodermic needles and syringes returned to the TO COLLECT RETURNED
RAPID ANALYSIS DRUGS20 NEEDLES AND SYRINGES AND SEND THEM TO THE OF
CENTER HARM REDUCTION MARYLAND21 PROGRAM OPERATED BY THE FOR AT THE
DEPARTMENT HEALTH.22 OF

23 (d) On or before December 31 of each year, the Baltimore City Health Department
24 shall report to the oversight committee, the Governor, and, in accordance with § 2–1257 of
25 the State Government Article, the General Assembly, on the number of hypodermic needles
26 and syringes exchanged as part of the Program.

27 24–808.

[(a)]28 No Program staff member or Program participant may be found guilty of
29 violating § 5–601, § 5–619, § 5–620, § 5–902, or § 5–904 of the Criminal Law Article for
30 possessing or distributing controlled paraphernalia or drug paraphernalia whenever the
31 possession or distribution of the controlled paraphernalia or drug paraphernalia is a direct
32 result of the employee’s or participant’s activities in connection with the work of the
33 Program authorized under this subtitle.

PAGE 7
HOUSE BILL 1502 7

[(b)1 Notwithstanding the provisions of subsection (a) of this section, a Program
2 staff member or Program participant is not immune from criminal prosecution for:

3 (1) The redistribution of hypodermic needles or syringes in any form;

4 (2) Any activities not authorized or approved by the Program; or

5 (3) The possession or distribution of controlled paraphernalia or drug
limits.]6 paraphernalia or any other unlawful activity outside of the Baltimore City

7 24–809.

8 Except for violations of any laws that could arise from residue attached to or
9 contained within hypodermic needles or syringes being returned or already returned to the
[nothing in] [provides]10 Program, this subtitle immunity to a ProgramDOES NOT PROVIDE
11 staff member or Program participant from criminal prosecution for a violation of any law
12 prohibiting or regulating the use, possession, dispensing, distribution, or promotion of
[controlled13 dangerous substances, dangerous drugs, detrimental drugs, or harmful drugs
offenses]14 or any conspiracy or attempt to commit any of those DRUGS.ILLICIT

15 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect
16 October 1, 2025.

Approved:

________________________________________________________________________________
Governor.

________________________________________________________________________________
Speaker of the House of Delegates.

________________________________________________________________________________
President of the Senate.